دورية أكاديمية
أعرض في EDS

Bio-Prospecting of Crude Leaf Extracts from Thirteen Plants of Brazilian Cerrado Biome on Human Glioma Cell Lines.

التفاصيل البيبلوغرافية
العنوان: Bio-Prospecting of Crude Leaf Extracts from Thirteen Plants of Brazilian Cerrado Biome on Human Glioma Cell Lines.
المؤلفون: Silva VAO; Molecular Oncology Research Center, Barretos Cancer Hospital, São Paulo 14784-400, Brazil.; Department of Pathology, School of Medicine of the Federal University of Bahia, Salvador 40170-110, Brazil.; Gonçalo Moniz Institute, Oswaldo Cruz Foundation (IGM-FIOCRUZ/BA), Salvador 40296-710, Brazil., Rosa MN; Molecular Oncology Research Center, Barretos Cancer Hospital, São Paulo 14784-400, Brazil., Gomes INF; Molecular Oncology Research Center, Barretos Cancer Hospital, São Paulo 14784-400, Brazil., Vital PDS; Molecular Oncology Research Center, Barretos Cancer Hospital, São Paulo 14784-400, Brazil., Alves ALV; Molecular Oncology Research Center, Barretos Cancer Hospital, São Paulo 14784-400, Brazil., Evangelista AF; Molecular Oncology Research Center, Barretos Cancer Hospital, São Paulo 14784-400, Brazil., Longato GB; Molecular Oncology Research Center, Barretos Cancer Hospital, São Paulo 14784-400, Brazil.; Research Laboratory in Cellular and Molecular Biology of Tumors and Bioactive Compounds, San Francisco University, Bragança Paulista, São Paulo 12916-900, Brazil., Carloni AC; Molecular Oncology Research Center, Barretos Cancer Hospital, São Paulo 14784-400, Brazil., Oliveira BG; Petroleomic and Forensic Laboratory, Chemistry Department, Federal University of Espírito Santo, Vitória 29075-910, Brazil., Pinto FE; Petroleomic and Forensic Laboratory, Chemistry Department, Federal University of Espírito Santo, Vitória 29075-910, Brazil., Romão W; Petroleomic and Forensic Laboratory, Chemistry Department, Federal University of Espírito Santo, Vitória 29075-910, Brazil., Rezende AR; Ituiutaba Unit, Department of Agrarian and Natural Sciences (DECAN), State University of Minas Gerais (UEMG), Divinopolis 38302-192, Brazil., Araújo AAC; Ituiutaba Unit, Department of Agrarian and Natural Sciences (DECAN), State University of Minas Gerais (UEMG), Divinopolis 38302-192, Brazil., Oliveira LSFM; Laboratory of Experimental Pathology, Federal University of São João del Rei-CCO/UFSJ, Divinópolis 35501-296, Brazil., Souza AAM; Laboratory of Experimental Pathology, Federal University of São João del Rei-CCO/UFSJ, Divinópolis 35501-296, Brazil., Oliveira SC; Laboratory of Experimental Pathology, Federal University of São João del Rei-CCO/UFSJ, Divinópolis 35501-296, Brazil., Ribeiro RIMA; Laboratory of Experimental Pathology, Federal University of São João del Rei-CCO/UFSJ, Divinópolis 35501-296, Brazil., Reis RM; Molecular Oncology Research Center, Barretos Cancer Hospital, São Paulo 14784-400, Brazil.; Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, 4710-057 Braga, Portugal.; ICVS/3B's-PT Government Associate Laboratory, 4710-057 Braga, Portugal.
المصدر: Molecules (Basel, Switzerland) [Molecules] 2023 Feb 01; Vol. 28 (3). Date of Electronic Publication: 2023 Feb 01.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-3049 (Electronic) Linking ISSN: 14203049 NLM ISO Abbreviation: Molecules Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Basel, Switzerland : MDPI, c1995-
مواضيع طبية MeSH: Antineoplastic Agents*/pharmacology , Melastomataceae*/chemistry , Glioma*/drug therapy, Humans ; Brazil ; Chloroform ; Cell Line ; Plant Extracts/pharmacology ; Ecosystem
مستخلص: (1) Background: Malignant gliomas are aggressive tumors characterized by fast cellular growth and highly invasive properties. Despite all biological and clinical advances in therapy, the standard treatment remains essentially palliative. Therefore, searching for alternative therapies that minimize adverse symptoms and improve glioblastoma patients' outcomes is imperative. Natural products represent an essential source in the discovery of such new drugs. Plants from the cerrado biome have been receiving increased attention due to the presence of secondary metabolites with significant therapeutic potential. (2) Aim: This study provides data on the cytotoxic potential of 13 leaf extracts obtained from plants of 5 families (Anacardiaceae, Annonaceae, Fabaceae, Melastomataceae e Siparunaceae) found in the Brazilian cerrado biome on a panel of 5 glioma cell lines and one normal astrocyte. (3) Methods: The effect of crude extracts on cell viability was evaluated by MTS assay. Mass spectrometry (ESI FT-ICR MS) was performed to identify the secondary metabolites classes presented in the crude extracts and partitions. (4) Results: Our results revealed the cytotoxic potential of Melastomataceae species Miconia cuspidata, Miconia albicans, and Miconia chamissois . Additionally, comparing the four partitions obtained from M. chamissois crude extract indicates that the chloroform partition had the greatest cytotoxic activity against the glioma cell lines. The partitions also showed a mean IC 50 close to chemotherapy, temozolomide; nevertheless, lower toxicity against normal astrocytes. Analysis of secondary metabolites classes presented in these crude extracts and partitions indicates the presence of phenolic compounds. (5) Conclusions: These findings highlight M. chamissois chloroform partition as a promising component and may guide the search for the development of additional new anticancer therapies.
Competing Interests: The authors declare no conflict of interest.
References: N Engl J Med. 2022 May 19;386(20):1922-1931. (PMID: 35584157)
Cancer Res. 2012 Apr 1;72(7):1614-20. (PMID: 22311673)
Lancet Oncol. 2017 Jun;18(6):e315-e329. (PMID: 28483413)
Z Naturforsch C J Biosci. 2006 Jul-Aug;61(7-8):477-82. (PMID: 16989305)
Expert Rev Neurother. 2015;15(8):935-46. (PMID: 26118735)
Oxid Med Cell Longev. 2019 Aug 25;2019:3685264. (PMID: 31534620)
Nat Prod Res. 2013;27(12):1091-7. (PMID: 22690913)
J Ethnopharmacol. 2012 Mar 6;140(1):197-201. (PMID: 22226976)
Evid Based Complement Alternat Med. 2019 Sep 5;2019:6316231. (PMID: 31662777)
Molecules. 2014 Jul 03;19(7):9453-77. (PMID: 24995927)
Sci Rep. 2019 Nov 22;9(1):17430. (PMID: 31758082)
Med Princ Pract. 2016;25 Suppl 2:41-59. (PMID: 26679767)
Int J Mol Sci. 2015 Oct 09;16(10):23760-83. (PMID: 26473827)
Nat Prod Rep. 2005 Apr;22(2):269-303. (PMID: 15806200)
Molecules. 2022 Feb 08;27(3):. (PMID: 35164385)
Neurosurg Focus. 2014 Sep;37(3):E11. (PMID: 25175430)
J Ethnopharmacol. 2014 Dec 2;158 Pt A:404-11. (PMID: 25456437)
Phytochem Anal. 2011 Nov-Dec;22(6):516-25. (PMID: 21495106)
Neuro Oncol. 2015 Oct;17(10):1322-32. (PMID: 26203067)
Biochem Pharmacol. 1997 Jan 24;53(2):121-33. (PMID: 9037244)
Life Sci. 2021 Dec 1;286:120046. (PMID: 34653428)
Cells. 2021 Mar 20;10(3):. (PMID: 33804755)
Front Plant Sci. 2017 Apr 13;8:551. (PMID: 28450876)
CA Cancer J Clin. 2022 Jan;72(1):7-33. (PMID: 35020204)
Int J Oncol. 2008 Feb;32(2):451-8. (PMID: 18202768)
Anticancer Agents Med Chem. 2013 Oct;13(8):1236-58. (PMID: 23796249)
Biomed Res Int. 2018 Mar 25;2018:4702481. (PMID: 29770331)
Neuropharmacology. 2010 May;58(6):903-10. (PMID: 20045420)
Lancet. 2018 Aug 4;392(10145):432-446. (PMID: 30060998)
Biomol Ther (Seoul). 2022 Nov 1;30(6):576-584. (PMID: 35934668)
Molecules. 2017 Mar 17;22(3):. (PMID: 28304342)
Invest New Drugs. 2020 Aug;38(4):1044-1055. (PMID: 31781904)
An Acad Bras Cienc. 2018 Apr 16;90(1 Suppl 1):763-778. (PMID: 29668803)
Melanoma Res. 2014 Aug;24(4):342-8. (PMID: 24743052)
J Ethnopharmacol. 2020 Oct 5;260:112547. (PMID: 31917276)
Int J Mol Sci. 2016 Nov 08;17(11):. (PMID: 27834805)
Invest New Drugs. 2019 Aug;37(4):602-615. (PMID: 30155717)
Science. 2014 Jun 20;344(6190):1396-401. (PMID: 24925914)
Mini Rev Med Chem. 2015;15(1):52-7. (PMID: 25986040)
Oncol Lett. 2012 May;3(5):1069-1072. (PMID: 22783393)
Evid Based Complement Alternat Med. 2011;2011:365359. (PMID: 21528006)
Pak J Pharm Sci. 2021 Mar;34(2):599-606. (PMID: 34275835)
Expert Rev Mol Med. 2021 Dec 02;23:e20. (PMID: 34852856)
Phytochemistry. 2002 Oct;61(4):461-4. (PMID: 12377244)
Mol Med Rep. 2014 Aug;10(2):1046-50. (PMID: 24889088)
Molecules. 2010 Dec 07;15(12):8953-66. (PMID: 21139533)
Int J Mol Sci. 2013 Feb 26;14(3):4629-39. (PMID: 23443162)
Nat Rev Neurol. 2022 Sep;18(9):515-529. (PMID: 35729337)
BMC Complement Altern Med. 2016 Oct 22;16(1):403. (PMID: 27770779)
Molecules. 2015 Sep 25;20(10):17818-47. (PMID: 26404220)
J Ethnopharmacol. 2005 May 13;99(1):37-41. (PMID: 15848017)
PLoS One. 2015 Mar 18;10(3):e0118864. (PMID: 25785932)
An Acad Bras Cienc. 2021 Oct 29;93(suppl 3):e20191101. (PMID: 34730736)
Sci Rep. 2017 Sep 12;7(1):11277. (PMID: 28900281)
Neuro Oncol. 2016 Jan;18(1):27-36. (PMID: 26359209)
Int J Mol Sci. 2021 Mar 25;22(7):. (PMID: 33806119)
J Environ Manage. 2019 Feb 15;232:818-828. (PMID: 30529869)
Stem Cell Res Ther. 2021 Mar 24;12(1):206. (PMID: 33762015)
J Neurochem. 2006 Feb;96(3):766-76. (PMID: 16405512)
Phytother Res. 2011 Oct;25(10):1447-50. (PMID: 21351299)
Vet Sci. 2022 Nov 16;9(11):. (PMID: 36423085)
N Engl J Med. 2005 Mar 10;352(10):987-96. (PMID: 15758009)
J Ethnopharmacol. 2009 Jun 25;123(3):439-45. (PMID: 19501276)
Org Biomol Chem. 2014 Oct 21;12(39):7673-7. (PMID: 25167470)
معلومات مُعتمدة: DECIT-01/2013 FINEP (MCTI/FINEP/MS/SCTIE/DECIT-01/2013 - FPXII-BIOPLAT)
فهرسة مساهمة: Keywords: Melastomataceae; cerrado biome; cytotoxic activity; glioma; plant extracts
المشرفين على المادة: 7V31YC746X (Chloroform)
0 (Antineoplastic Agents)
0 (Plant Extracts)
تواريخ الأحداث: Date Created: 20230211 Date Completed: 20230214 Latest Revision: 20230214
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC9921846
DOI: 10.3390/molecules28031394
PMID: 36771057
قاعدة البيانات: MEDLINE
الوصف
تدمد:1420-3049
DOI:10.3390/molecules28031394